The power and the promise of oncogene-induced senescence markers
- 1 June 2006
- journal article
- innovation
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 6 (6) , 472-476
- https://doi.org/10.1038/nrc1884
Abstract
Recently, it has been shown that oncogene-induced senescence (OIS) occurs during the early stages of tumorigenesis. Senescent tumour cells are abundant within premalignant neoplastic lesions, whereas they are scarce in malignant tumours. This association of senescence with the premalignant stages of tumour progression opens the possibility of using senescence markers as diagnostic and prognostic tools. Moreover, some chemotherapeutic protocols induce senescence in tumour cells and, consequently, senescence markers could help to monitor treatment response.Keywords
This publication has 47 references indexed in Scilit:
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisNature, 2005
- BRAFE600-associated senescence-like cell cycle arrest of human naeviNature, 2005
- Oncogene-induced senescence as an initial barrier in lymphoma developmentNature, 2005
- Senescence in premalignant tumoursNature, 2005
- Intrinsic tumour suppressionNature, 2004
- The limited in vitro lifetime of human diploid cell strainsPublished by Elsevier ,2004
- Hallmarks of senescence in carcinogenesis and cancer therapyOncogene, 2004
- Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular contextCancer Cell, 2003
- Putting the stress on senescenceCurrent Opinion in Cell Biology, 2001
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997